📅 PREDICTFTD is heading to ISFTD 2026!

PREDICTFTD will also be featured in a poster presentation at the 15th International Conference on Frontotemporal Dementias.

Join ISFTD's Webinar on AI in FTD: From Neuropathology to MRI to Clinic

Wednesday, 29th October, 2025 at 11:00 AM EST.

www.isftd.org/events/webin...

#endFTD
#ISFTD

What a year it has been! I went back to @frontier-usyd.bsky.social in Sydney, went back to Amsterdam to defend my PhD, helped organize the #ISFTD conference and then started my post-doc at the Alzheimercentrum Amsterdam! Let’s see what 2025 brings! #PhD #FTD

🎉 Congratulations to Dr. Ducharme on his election as President-elect of the International Society for Frontotemporal Dementias (ISFTD)!
buff.ly/AGJiBbE

****

🎉 Félicitations au Dr Ducharme, élu président désigné de l’International Society for Frontotemporal Dementias (ISFTD)!
buff.ly/7KSFGqw

Dr. David Irwin, Associate Professor and Co-Director of the Penn FTD Center, was appointed chair-elect of the Scientific Program Committee to the Executive Board of Directors with the International Society for Frontotemporal Degeneration (ISFTD).

Congrats Dr. Irwin! 🎉

Join us at the 15th #ISFTD International Conference in Philadelphia next week to learn how datasets from NIAGADS can help advance your FTD research!
Look for us at Booth 4TT on Oct 8-10 (Thur-Sat). Our first session will be Thursday 12-7. Hope to see you there!

NEWS: ( NASDAQ: #ALEC ) Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

#StockMarket #News

The Penn FTD Center is delighted to be working with ISFTD to host Caregivers Day, a one-day conference for family members and professional caregivers to learn more about advances in research and approaches to care.

Use the link in our bio to get more information and register today!

Caregivers are invited to join us for Caregivers Day at ISFTD 2026 on Friday, October 9 in Philadelphia. This one-day conference features expert-led sessions on FTD care, the latest research advances, symptom management, advocacy, and more.

Register now at the link in our bio!

CervoMed's neflamapimod shows measurable plasma biomarker shifts in nfvPPA at 12 weeks, across 22+ participants in Phase 2a. Data presentation at ISFTD signals progression toward clinically relevant endpoints.

Die Strompreise in Deutschland gehörten zu den höchsten weltweit, sagte Verivox-Energieexperte Thorsten Storck. Das liege auch daran, dass die Stromproduktion selbst nur etwa ein Drittel des Strompreises für Haushalte ausmache.🔌
archive.ph/ISftD

Josh Stott form @ADAPTlabUCL will be talking at the #FTD @RareDementia meeting about our "Better Living with bvFTD".

This is a 6 module training course #Coproduced with families of people with #bvFTD.

@rdscanada @isftd @RDS_ImpactStudy @ftdnews @AFTDHope

ISFTD EMCR (Early to Mid Career Research) will be hosting a symposium April 14-16 with a variety of researchers including former Penn FTD Center postdoctoral researcher, Ting Shen. For full schedule, registration, and further details, use the link below!

www.isftd.org/emcr-symposi...

🎧 New #Podcast! Join Dr Anna Volkmer, Dr Aitana Sogorb-Esteve, and Dr Martyna Matuszyk as they break down the highlights from the #ISFTD24 Conference. Get the latest on fluid biomarkers, therapies, diagnosis, cognitive resilience & more! 🌍🧠

pod.fo/e/26e89d

Pleased to be bringing you highlights from last weeks #ISFTD24 Conference

youtu.be/1Ctm06jf1-I